Min Xiao

This publication record, listed under the name Min Xiao, spans a wide range of biomedical topics including CAR-T cell engineering for leukemia and lymphoma, cancer genetics (e.g., TP53, TET2, DNMT3A mutations), breast and lung cancer treatment outcomes, and clinical studies on infectious disease and nephrology, alongside unrelated engineering papers on aircraft control systems. Because the topic relevance scores are all listed as 0.00 and the subject matter is highly heterogeneous, it is likely that this record aggregates work from multiple different researchers sharing the same name rather than a single coherent research program. Prospective students should independently verify which specific papers and institution correspond to the Min Xiao they are interested in.

Publication counts were relatively steady (15-42 per year) from 2017-2022, spiked sharply to 177 in 2023, then dropped back to 30 in 2024 and 18 in 2025, a pattern consistent with multiple distinct authors being merged under one name rather than a single growing research output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026